Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,305
Total Claims
$1.1M
Drug Cost
589
Beneficiaries
$1,910
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 18,720 Cardiology providers
+25%
Cost per patient vs peers
$1,910 vs $1,524 avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.6%
Opioid Rate
241
Opioid Claims
$3,071
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,259 claims · $932K
Generic: 7,933 claims · $189K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 210 | $240K |
| Sitagliptin Phosphate | 71 | $97K |
| Empagliflozin | 76 | $85K |
| Sacubitril/Valsartan | 85 | $77K |
| Rivaroxaban | 29 | $29K |
| Linagliptin | 27 | $20K |
| Budesonide/Formoterol Fumarate | 42 | $20K |
| Dulaglutide | 13 | $20K |
| Ipratropium/Albuterol Sulfate | 22 | $18K |
| Ipratropium Bromide | 15 | $16K |
| Insulin Detemir | 25 | $16K |
| Lipase/Protease/Amylase | 13 | $12K |
| Tiotropium Bromide | 14 | $12K |
| Insulin Glargine,hum.Rec.Anlog | 20 | $11K |
| Exenatide | 12 | $11K |
Prescribing Profile
Patient Profile
74
Avg Age
58%
Female
1.85
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About